BRD2 and astrocytoma (excluding glioblastoma): Among the mRNAs detected, 3547 mRNAs with a fold change > 2 or < 0.5 and a p value < 0.05 were found to have significantly different expression levels in astrocytoma samples compared to NAT samples.